Neoplasms
|
0.030 |
GeneticVariation
|
group |
BEFREE |
A prediction algorithm (SUMSCAN) based on the presence of specific gene gains (Tumor Target Charge, TTC) and losses (Tumor Target Losses, TTL) was conceived and validated in 2 independent validation cohorts.
|
26317543 |
2015 |
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
To understand the molecular and genetic bases of neuroblastoma, we have generated its cDNA libraries and identified a human ortholog of tubulin tyrosine ligase gene (hTTL/Nbla0660) as a differentially expressed gene at high levels in a favorable subset of the tumor.
|
15382060 |
2004 |
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
We conclude there is a widespread loss of TTL activity during tumor growth in situ, suggesting that TTL activity may play a role in tumor cell regulation.
|
9405300 |
1998 |
Malignant neoplasm of urinary bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Importantly, catechol-O-methyltransferase, iodotyrosine deiodinase, and tubulin tyrosine ligase showed a significant association with patient survival in publicly available bladder cancer smoker datasets and did not have any clinical association in never smokers.
|
30642841 |
2019 |
Bladder Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
Importantly, catechol-O-methyltransferase, iodotyrosine deiodinase, and tubulin tyrosine ligase showed a significant association with patient survival in publicly available bladder cancer smoker datasets and did not have any clinical association in never smokers.
|
30642841 |
2019 |
Carcinoma of bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Importantly, catechol-O-methyltransferase, iodotyrosine deiodinase, and tubulin tyrosine ligase showed a significant association with patient survival in publicly available bladder cancer smoker datasets and did not have any clinical association in never smokers.
|
30642841 |
2019 |
Fibrosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
To validate our finding, the function of one of the candidate genes, tubulin tyrosine ligase (<i>Ttl</i>), was further studied in TAFs from fibrosarcoma, colon, breast and hepatocarcinoma.
|
29228606 |
2017 |
Adult Fibrosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
To validate our finding, the function of one of the candidate genes, tubulin tyrosine ligase (<i>Ttl</i>), was further studied in TAFs from fibrosarcoma, colon, breast and hepatocarcinoma.
|
29228606 |
2017 |
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
To validate our finding, the function of one of the candidate genes, tubulin tyrosine ligase (<i>Ttl</i>), was further studied in TAFs from fibrosarcoma, colon, breast and hepatocarcinoma.
|
29228606 |
2017 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance.
|
24814394 |
2014 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance.
|
24814394 |
2014 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance.
|
24814394 |
2014 |
Neuroblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis.
|
15382060 |
2004 |
Sarcoma
|
0.010 |
Biomarker
|
group |
BEFREE |
When injected into nude mice, both TTL- cells and TTL- cells stably transfected with TTL cDNA form sarcomas.
|
9405300 |
1998 |
Malignant neoplasm of soft tissue
|
0.010 |
Biomarker
|
group |
BEFREE |
When injected into nude mice, both TTL- cells and TTL- cells stably transfected with TTL cDNA form sarcomas.
|
9405300 |
1998 |